Mdm2 and MdmX: Partners in p53 Destruction
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Mdm2 and MdmX are two closely related proteins that have been well-characterized as negative regulators of the tumor suppressor p53. Their interplay and especially respective roles in ubiquitination and subsequent degradation of p53 have lacked clarity. Yang and colleagues now demonstrate an obligate role for MdmX in recruitment of the E2 ubiquitin ligase UbcH5c to the Mdm2-MdmX hetero-oligomer. The use of elegant genetically engineered mouse models ensures the biological relevance of their findings that have important implications for targeted therapies involving these key players in the p53 pathway. See related article by Yang et al., Cancer Res 2021;81:898–909.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the overexpression of MDM2/4 results in the inactivation of p53, which has been observed in various human tumors.198,199”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [198]
In the citing paper
“Overexpression or activation of MDM2/MDM4 is present in many human tumors, leading to p53 inactivation.334,339,340”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [334]
In the citing paper
“MDM2/MDMX is the major negative regulator of p53.334”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [334]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mdm2–p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
Manfredi, J. J. (2010) · Genes & Development · doi:10.1101/gad.1941710 · Cited by 344 · cited 4×
“Both of these effects are rescued by p53 loss (1, 2).”
BackgroundSelf-citationTissue-specific differences of p53 inhibition by Mdm2 and Mdm4
Grier, J. D., Xiong, S., Elizondo-Fraire, A. C., Parant, J. M., & Lozano, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.192-198.2006 · Cited by 149 · cited 1×
“Elegant mouse studies in which either Mdm2 or MdmX is targeted for deletion have revealed phenotypic differences (8).”
BackgroundPant, V., Xiong, S., Iwakuma, T., Quintás-Cardama, A., & Lozano, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102241108 · Cited by 134
Research works printed but not linked: 7
- Karni-Schmidt, 2016, The roles of MDM2 and MDMX in cancer, Ann Rev Pathol, 11, 617, 10.1146/annurev-pathol-012414-040349 · DOI · Paper page
- Yang, 2021, MDMX recruits UbcH5c to facilitate MDM2 E3 ligase activity and subsequent p53 degradation in vivo, Cancer Res, 81, 898, 10.1158/0008-5472.CAN-20-0790 · DOI
- Fahraeus, 2013, MDM2′s social network, Oncogene, 33, 4365, 10.1038/onc.2013.410 · DOI
- Xiong, 2017, The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis, J Pathol, 241, 501, 10.1002/path.4854 · DOI
- Li, 2013, Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy, Clin Cancer Res, 19, 34, 10.1158/1078-0432.CCR-12-0053 · DOI · Paper page
- Terzian, 2008, The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss, Genes Dev, 22, 1337, 10.1101/gad.1662908 · DOI · Paper page
- Yang, 2018, Mutant p53 sequestration of MDM2 acidic domain inhibits E3 ligase activity, Mol Cell Biol, 39, e00375
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Therapeutics targeting p53-MDM2 interaction to induce cancer cell death
Koo, N., Sharma, A. K., & Narayan, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095005 · Cited by 153
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Metadata
- Authors
- Manfredi, J. J.
- Venue
- Cancer Research
- Published
- 2021-04-01
- Volume
- 81
- Issue
- 7
- Pages
- 1633-1634
- ISSN
- 0008-5472
- 1538-7445
- Cited by
- 28
- References
- 3
- Language
- en
- Funders
- NCI (R01 CA257548)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mdm2 and MdmX: Partners in p53 Destruction. https://app.cochat.ai/papers/10.1158/0008-5472.can-21-0145
- The paper
- Manfredi, J. J. (2021). Mdm2 and MdmX: Partners in p53 Destruction. Cancer Research. https://doi.org/10.1158/0008-5472.can-21-0145
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.